Clinical Trials
All Clinical Trials - Page 2 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07310420Phase 1Recruiting
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Gonadorelin
- NCT07871409Phase 3Not Yet Recruiting
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
Maridebart-Cafraglutide
- NCT07893457Phase 4Not Yet Recruiting
Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity
Tirzepatide
- NCT07825857Phase 2Recruiting
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Tirzepatide
- NCT07850063Phase 3Not Yet Recruiting
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Survodutide
- NCT07592546Phase 4Recruiting
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Semaglutide
- NCT07888595EARLY_Phase 1Enrolling By Invitation
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
GHK-Cu
- NCT07889453N/AActive Not Recruiting
Metabolic Effects of Switching From Injectable Semaglutide to Tirzepatide
Tirzepatide
- NCT07855315N/ANot Yet Recruiting
FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps
Desmopressin
- NCT07874828Phase 2Recruiting
PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
Tirzepatide
- NCT07874932N/ANot Yet Recruiting
Long-Term Effects of Semaglutide on Body Composition and Performance in Running
Semaglutide
- NCT07874971N/ANot Yet Recruiting
Short Term Effects of Semaglutide on Body Composition and Performance
Semaglutide
- NCT07881770N/ANot Yet Recruiting
Semaglutide Health Outcomes and Patient Adherence in Australia
Semaglutide
- NCT07891156Phase 2/Phase 3Recruiting
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Semaglutide
- NCT07832799Phase 1Not Yet Recruiting
Comparing the Extent to Which Two Maridebart Cafraglutide Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
Maridebart-Cafraglutide
- NCT07868354Phase 1Recruiting
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
Tirzepatide
- NCT07777575Phase 4Recruiting
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Tirzepatide
- NCT07866118N/ARecruiting
Thymalfasin for Immune Recovery in Adults With Sepsis
Thymosin-Alpha-1
- NCT07846865Phase 2/Phase 3Not Yet Recruiting
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial
Tirzepatide
- NCT07809568N/ANot Yet Recruiting
Real-World Outcomes of Tirzepatide in Pakistani Adults With Obesity, Prediabetes, and Type 2 Diabetes
Tirzepatide
- NCT07755085Phase 4Not Yet Recruiting
GLP-1s in Hip and Knee Arthroplasty
Semaglutide
- NCT07872904Phase 4Not Yet Recruiting
FutureShape Family
Semaglutide
- NCT07808879N/ARecruiting
Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization
Exenatide
- NCT07739537Phase 4Not Yet Recruiting
PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Orforglipron
- NCT07387796N/ARecruiting
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
Tirzepatide
- NCT07782359Phase 1Not Yet Recruiting
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
Tirzepatide
- NCT07758231Phase 1Not Yet Recruiting
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
Tirzepatide
- NCT07859137Phase 4Not Yet Recruiting
Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or Higher
Semaglutide
- NCT07859176Phase 4Not Yet Recruiting
Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery
Semaglutide
- NCT07859163Phase 4Not Yet Recruiting
Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain
Semaglutide
- NCT07389941Phase 4Not Yet Recruiting
Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation
Semaglutide
- NCT07677891Phase 2Not Yet Recruiting
Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus
Dulaglutide
- NCT07843862Phase 2Not Yet Recruiting
A Study of HRS-4729 Injection in Participants With Type 2 Diabetes
Mazdutide
- NCT07845500Phase 3Recruiting
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Tirzepatide
- NCT07767552N/ANot Yet Recruiting
Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
Mazdutide
- NCT07843472Phase 3Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
Petrelintide
- NCT07843485Phase 3Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
Petrelintide
- NCT07843498Phase 3Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
Petrelintide
- NCT07589686Phase 2Not Yet Recruiting
A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
Petrelintide
- NCT07817875Phase 3Recruiting
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Tirzepatide
- NCT07845578Phase 1Not Yet Recruiting
A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight
Semaglutide
- NCT07668414Phase 3Recruiting
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Semaglutide
- NCT07846956N/ANot Yet Recruiting
NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study
Tirzepatide
- NCT07734792Phase 2/Phase 3Not Yet Recruiting
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Tirzepatide
- NCT06073184Phase 2Recruiting
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
Semaglutide
- NCT07817251Phase 3Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Semaglutide
- NCT07734870Phase 2Recruiting
Tirzepatide for Treatment of CCCA
Tirzepatide
- NCT07713992N/ANot Yet Recruiting
Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
Semaglutide
- NCT07649421Phase 2Not Yet Recruiting
PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
Gonadorelin
- NCT07824895Phase 4Not Yet Recruiting
Mazdutide for Weight Management and Gout in Adults With Obesity
Mazdutide